corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8458

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Two-thirds of RPh's and MD's object to makers' promotion of Rx drugs to the public
American Druggist 1982 Oct; 186:14, 16, 21-22


Abstract:

Coordinated surveys of the reactions of physicians and pharmacists to the growing trend among pharmaceutical manufacturers to promote prescription drugs, particularly new ones, directly to the patients instead of the health professionals, are described. Results of the questionnaire surveys showed that 68.7% of pharmacists and a slightly lower proportion of physicians, 63.9%, object to the manufacturers’ promotions of the drugs to consumers. Among the physicians, internists and general practitioners are the least likely to disapprove of promotion to patients. Hospital pharmacists are more likely than community pharmacists to object to such promotions, and among the community pharmacists, the independents are more likely to object than the chain pharmacists. The pharmacists’ and physicians’ views on the promotion of prescription drugs to the public are tabulated.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.